ShiftPosts is raising funds on StartEngine at a valuation of $16.77 million. ShiftPosts generated approximately $4.8 million in revenue in the most recent fiscal year, representing a revenue multiple of 3.5. This multiple suggests that the company is very reasonably priced relative to its current revenue. At $16.77 million, the company is even undervalued relative to the online private markets. Considering the company's current revenue and growth prospects, the current valuation contributes to the high price score and represents a good deal for investors in this round. 

ShiftPosts operates in the healthcare staffing market, a sector that has seen significant growth due to factors such as the aging population, increased demand for healthcare services, and a shortage of healthcare professionals. At this time, ShiftPosts is fully operational in Canada, with plans to expand into the US. According to Grand View Research, the approximate healthcare staffing market size for the US and Canada is $24 billion. The market is expected to grow at a compound annual growth rate (CAGR) of 6.6%. ShiftPosts' current solution is specific to pharmacies, making the true addressable market much smaller, though the team has plans to expand into general healthcare staffing very soon.

The market is poised to grow for several reasons. The pandemic has amplified the need for healthcare staffing solutions. It has highlighted the importance of having an efficient system to manage staffing needs in healthcare facilities, from hospitals to pharmacies. This increased need for efficient staffing solutions bodes well for ShiftPosts, which provides an end-to-end workforce management platform specifically designed for the healthcare industry.

Regulations in the healthcare industry also play a significant role in driving the demand for solutions like ShiftPosts. Healthcare and pharmaceutical facilities need to ensure they are meeting regulatory standards and compliance requirements, which staffing software can simplify. However, the market is not without challenges. Integration with existing HR and healthcare systems can be complex, which could potentially slow adoption. 

Overall, the sizeable addressable market, combined with the growing demand for healthcare staffing solutions, presents a significant opportunity for ShiftPosts, significantly as the company expands into the US. 

ShiftPosts was co-founded by CEO Elizabeth Cooper, and Board Members Patrick Fry and Dave McLean. Cooper has a background in venture investing and entrepreneurship. Before founding ShiftPosts, she served as Global CEO of IDG Channels and sold her spin-out firm. Fry has spent more than 40 years at Sutter Health, a nonprofit healthcare provider. McLean also has an extensive background in healthcare, managing health-tech companies, including Medication Management Systems, Inc. (acquired by Genoa HealthCare), NovoLogix (acquired by CVS), and RxHub.

The ShiftPosts team is small but dedicated; product and business development team members support the founding team. The founding team's extensive expertise in healthcare staffing and technology development positions the company well to address the needs of medical facilities and healthcare professionals. Additionally, the founders' entrepreneurial experience will serve them well as they scale the company. Also of note, much of the founders' past ventures have been in the US, which is preferable as the team attempts to expand beyond Canada and into the States. With their combined experience and dedication, the team is well-equipped to drive the growth and success of ShiftPosts.

ShiftPosts is an end-to-end workforce management platform specifically designed for the pharmaceutical industry and expanding into healthcare. The platform offers a comprehensive solution to manage schedules, talent, and gaps in staffing, all from one screen. This centralized approach sets ShiftPosts apart from its competitors by providing a seamless experience for pharmaceutical facilities to fill shifts and manage their workforce efficiently. 

While there are no other major players in the Canadian pharmaceutical staffing market, the US healthcare staffing market does have several established players, such as GigWorx Healthcare, Shiftkey, FleetNurse, Nursa, and NuWest. These platforms, however, appear to have a focus on staffing per diem and travel nurses. Few, if any, offer pharmacy coverage. While ShiftPosts does plan to expand beyond Canada and into the healthcare market, the pharmacy staffing market may prove to be the most lucrative.  

ShiftPosts has gained significant credibility in pharmaceutical staffing, with over 70% of all retail pharmacies and hospitals in Canada registering on the platform. This adoption rate demonstrates the value and effectiveness of ShiftPosts in addressing the staffing needs of pharmacy facilities. Furthermore, ShiftPosts has been recognized as the top staffing solution in healthcare by HR Tech Magazine, further validating its differentiation and market position. If ShiftPosts can replicate this traction in the United States, it will be impressively distinguished from existing competition. 

ShiftPosts has shown impressive growth and success in the pharmaceutical staffing industry. The company's platform has gained significant traction and was featured as the top staffing solution in healthcare by HR Tech Magazine. Over 70% of all retail pharmacies and hospitals in Canada have registered on the ShiftPosts platform, indicating a strong market presence and adoption.

ShiftPosts has established major partnerships with prominent organizations in the industry, including McKesson, Rexall, PharmaChoice, Remedy's RX, The Medicine Shoppe, Guardian, the British Columbia Pharmacy Association, and the Canadian Pharmacists Association. These partnerships demonstrate the industry's recognition and trust in ShiftPosts as a reliable workforce management platform.

The company's revenue growth has been impressive, with annual revenue reaching $4.8 million in the most recent fiscal year, up from $2.1 million the year prior. This represents 126.6% year-over-year revenue growth.

Overall, ShiftPosts has demonstrated strong traction, revenue generation, and market adoption in the healthcare staffing industry. The company's strategic partnerships and innovative platform position it for continued success and expansion in the Canadian market and beyond.

Investing in ShiftPosts carries several risks that prospective investors should consider. First, the healthcare and pharmaceutical staffing industry is highly regulated, which presents a potential barrier to entry and ongoing operational challenges for ShiftPosts. The company must comply with license regulations when clearing staff, which could result in legal issues or delays. Regulatory compliance will also differ from country to country. ShiftPosts has performed well in Canada, but expanding into the US may present its own set of unique challenges. 

While the pharmaceutical staffing market is relatively untapped, ShiftPosts faces plenty of competition from other companies in the US healthcare staffing space, including GigWorx Healthcare, Shiftkey, FleetNurse, Nursa, and NuWest. This competitive landscape may impact ShiftPosts' market share and revenue growth should the team decide to expand into the already crowded US healthcare staffing market. 

ShiftPosts has disrupted the Canadian pharmaceutical staffing industry with its innovative workforce management platform. The company's end-to-end solution streamlines scheduling, talent management, and gap-filling for pharmacy staff from a single screen. By consolidating multiple tasks into a few seamless actions, ShiftPosts enables pharmaceutical facilities to easily fill shifts and ensures a seamless staffing process.

ShiftPosts has already demonstrated its ability to capture market share and generate substantial sales, with $4.78 million in annual revenue for the most recent fiscal year. In under three years, the team has registered over 70% of all retail pharmacies and hospitals in Canada. With plans to expand abroad and into healthcare staffing, the company is well-positioned to continue a strong growth trajectory. Additionally, with $4.7 million in prior capital raised, there is already demonstrated confidence in the ShiftPosts solution. Finally, while there are plenty of direct competitors in the US healthcare staffing market, very few solutions directly tackle pharmaceutical staffing, and ShiftPosts has a clear lead in the Canadian market. 

ShiftPosts has emerged as an industry leader for pharmaceutical staffing in Canada. That said, the Canadian market is limited, and ShiftPosts has already tapped much of the market, with over 70% of all retail pharmacies and hospitals in Canada registered with the platform. Plans to expand into the US and more general healthcare staffing are in the works. Entering a new market, however, can be challenging from both a regulatory standpoint and with existing competition. There are several competitors, such as GigWorx Healthcare, Shiftkey, FleetNurse, Nursa, and NuWest, already offering healthcare staffing solutions in the US. ShiftPosts will have to compete in an entirely new market with existing market leaders and new regulatory challenges. 

ShiftPosts is a workforce management platform specifically designed for the pharmaceutical industry. First launched in Canada, it provides a comprehensive solution for managing schedules, filling talent gaps, and streamlining various tasks into simple actions. The platform ensures seamless staffing by qualifying professionals and enables facilities to fill empty shifts efficiently. ShiftPosts has already garnered significant attention and has been featured as the top staffing solution in healthcare by HR Tech Magazine. Over 70% of all retail pharmacies and hospitals in Canada have registered on the platform.

ShiftPosts is still in the pre-profit phase, with a net income loss in the most recent fiscal year. That said, the company's revenue growth has been substantial, with a total annual revenue of $4.78 million for the most recent fiscal year, up from $2.1 million the year prior. 

Finally, seeing as ShiftPosts has tapped much of the Canadian pharmaceutical market, the team has plans to expand abroad and into general healthcare staffing. This opportunity for growth is exciting but presents several challenges, including existing competition and regulatory compliance. If the team can successfully execute these expansion plans, enter a new market, and compete with existing platforms, investors in this round may see substantial returns. Overall, ShiftPosts is an exciting opportunity for investors looking to put capital into health tech.